These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 29241593)

  • 21. Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.
    Refardt J; Atila C; Chifu I; Ferrante E; Erlic Z; Drummond JB; Indirli R; Drexhage RC; Sailer CO; Widmer A; Felder S; Powlson AS; Hutter N; Vogt DR; Gurnell M; Soares BS; Hofland J; Beuschlein F; Fassnacht M; Winzeler B; Christ-Crain M
    N Engl J Med; 2023 Nov; 389(20):1877-1887. PubMed ID: 37966286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.
    Winzeler B; Cesana-Nigro N; Refardt J; Vogt DR; Imber C; Morin B; Popovic M; Steinmetz M; Sailer CO; Szinnai G; Chifu I; Fassnacht M; Christ-Crain M
    Lancet; 2019 Aug; 394(10198):587-595. PubMed ID: 31303316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications.
    Choy KW; Wijeratne N; Chiang C; Don-Wauchope A
    Crit Rev Clin Lab Sci; 2024 Jul; ():1-21. PubMed ID: 39086073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children.
    Bonnet L; Marquant E; Fromonot J; Hamouda I; Berbis J; Godefroy A; Vierge M; Tsimaratos M; Reynaud R
    Clin Endocrinol (Oxf); 2022 Jan; 96(1):47-53. PubMed ID: 34694022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrogenic diabetes insipidus: a comprehensive overview.
    Vaz de Castro PAS; Bitencourt L; de Oliveira Campos JL; Fischer BL; Soares de Brito SBC; Soares BS; Drummond JB; Simões E Silva AC
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):421-434. PubMed ID: 35146976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of central diabetes insipidus in adults.
    Garrahy A; Moran C; Thompson CJ
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):23-30. PubMed ID: 30269342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Accuracy of Copeptin in the Differential Diagnosis of Patients With Diabetes Insipidus: A Systematic Review and Meta-analysis.
    Mu D; Ma Y; Cheng J; Qiu L; Chen S; Cheng X
    Endocr Pract; 2023 Aug; 29(8):644-652. PubMed ID: 37225043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of copeptin in the diagnosis of traumatic neuroendocrine dysfunction.
    Săcărescu A; Turliuc MD; Brănișteanu DD
    Neuropeptides; 2021 Oct; 89():102167. PubMed ID: 34175655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of diagnostic methods to differentiate diabetes insipidus from primary polyuria: a review of 21 patients.
    Milles JJ; Spruce B; Baylis PH
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):410-6. PubMed ID: 6659843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of the water deprivation test in the polyuria-polydipsia syndrome.
    Trimpou P; Olsson DS; Ehn O; Ragnarsson O
    Hormones (Athens); 2017 Oct; 16(4):414-422. PubMed ID: 29518762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights on diagnosis and treatment of AVP deficiency.
    Refardt J; Atila C; Christ-Crain M
    Rev Endocr Metab Disord; 2024 Jun; 25(3):639-649. PubMed ID: 38087160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome.
    Urwyler SA; Timper K; Fenske W; de Mota N; Blanchard A; Kühn F; Frech N; Arici B; Rutishauser J; Kopp P; Stettler C; Müller B; Katan M; Llorens-Cortes C; Christ-Crain M
    J Clin Endocrinol Metab; 2016 May; 101(5):1917-23. PubMed ID: 26967692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay.
    Katan M; Morgenthaler NG; Dixit KC; Rutishauser J; Brabant GE; Müller B; Christ-Crain M
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2640-3. PubMed ID: 17426098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and Management of Central Diabetes Insipidus in Adults.
    Tomkins M; Lawless S; Martin-Grace J; Sherlock M; Thompson CJ
    J Clin Endocrinol Metab; 2022 Sep; 107(10):2701-2715. PubMed ID: 35771962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gestational diabetes insipidus: Diagnosis and management.
    Ananthakrishnan S
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101384. PubMed ID: 32205050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin and Copeptin in health and disease.
    Christ-Crain M
    Rev Endocr Metab Disord; 2019 Sep; 20(3):283-294. PubMed ID: 31656992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of diabetes insipidus for the internist: an update.
    Christ-Crain M; Winzeler B; Refardt J
    J Intern Med; 2021 Jul; 290(1):73-87. PubMed ID: 33713498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Copeptin is a new diagnostic biomarker for diabetes insipidus].
    Stankovic J; Rittig S; Jørgensen JOL; Søndergaard E
    Ugeskr Laeger; 2020 Dec; 182(51):. PubMed ID: 33317692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The laboratory investigation of diabetes insipidus: A review.
    Boot C
    Ann Clin Biochem; 2024 Jan; 61(1):19-31. PubMed ID: 36650746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Clinical Utility of Copeptin (C-terminal provasopressin) measurements in clinical medicine.
    Lewandowski KC; Brabant G
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):173-7. PubMed ID: 27008633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.